EP Patent

EP2314298A1 — Microparticles comprising diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery

Assigned to Mannkind Corp · Expires 2011-04-27 · 15y expired

What this patent protects

Microparticles comprising a pharmaceutically acceptable salt of a heterocyclic compound and a biologically active agent, wherein said microparticles release said biologically active agent, and said heterocyclic compound has the structure according to Formula 1: wherein R 1 …

USPTO Abstract

Microparticles comprising a pharmaceutically acceptable salt of a heterocyclic compound and a biologically active agent, wherein said microparticles release said biologically active agent, and said heterocyclic compound has the structure according to Formula 1: wherein R 1 or R 2 comprise at least one carboxylate functional group; E 1 and E 2 are either N or O; and said salt further comprises at least one cation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2314298A1
Jurisdiction
EP
Classification
—
Expires
2011-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.